InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Chen Hubert C, Directeur Médical. Insider active across 2 companies, notably Metacrine, Inc.. Cumulatively, 7 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €19k. History available since 20 May 2021. The latest transaction was disclosed on 1 January 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
7,500 shares0Common StockSEC:0001209191-24-000326:0
7,500 shares0Common StockSEC:0001209191-23-051484:0
74,257 shares@ US$1.01100.0% of flowCommon StockSEC:0001209191-23-044282:0
7,500 shares0Common StockSEC:0001209191-23-040978:0
7,500 shares0Common StockSEC:0001209191-23-023076:0
3,289 shares@ US$3.6050.0% of flowCommon StockSEC:0001209191-21-034595
Ideal exit: 14 Feb 2022 (T+270)
3,289 shares@ US$3.6050.0% of flowCommon StockSEC:0001209191-21-034595:0
Ideal exit: 14 Feb 2022 (T+270)
7 of 7 declarations
About Chen Hubert C
Chen Hubert C is the Chief Medical Officer at Metacrine, Inc. He oversees the medical operations of the company, ensuring efficiency and compliance of processes. His role is crucial for product development and innovation in the biopharmaceutical sector.
